Exim Pharma SRL
1.0 FTEExim Pharma reported total assets of 354,353 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Oct 2026), with 1 full-time equivalent.
The score of Exim Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +580 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Exim Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Net result | −190,058 € | |||
| Equity | −546,144 € | |||
| Cash | 10,758 € | |||
| EBITDA | −186,186 € | |||
| Total assets | 354,353 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Oct 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
Exim Pharma's financial analysis
- Solvency-154.1%sector median: 25.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Exim Pharma
Exim Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0773.362.489
- VAT number
- BE0773362489
- Peppol
- Registered · 0208:0773362489 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Aug 2021
- Registered office
- 1050 Ixelles
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 12 Oct 2026
- Activity
- Wholesale of other food n.e.c. (NACE 46389)
Exim Pharma (SRL) has been based in Ixelles since 2021, active in: wholesale of other food n.e.c.. For 2025, it reports a net loss of 190,058 € and equity of −546,144 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -154.1%, below the median of its sector (25.4%).
Companies similar to Exim Pharma
Companies in the same business, of comparable size and area, outside its group.
- BIMEX Analytics Wholesale of pharmaceutical and medical goods Uccle · balance sheet 592,212 €
- Meditor Benelux Wholesale of pharmaceutical and medical goods Brussels · balance sheet 735,858 €
- Alexion Services Europe Wholesale of pharmaceutical and medical goods Brussels · balance sheet 742,735 €
- Mark Schneider Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet 113,169 €
- Moleac Belgium Wholesale of pharmaceutical and medical goods Auderghem · balance sheet €1.79m
- Medispar Wholesale of pharmaceutical and medical goods Brussels · balance sheet €2.72m
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
Frequently asked questions about Exim Pharma
What is the revenue of Exim Pharma?
Exim Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Exim Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0773362489 for Exim Pharma, if the company is VAT-registered. Its company number (CBE) is 0773.362.489.
Where is the registered office of Exim Pharma?
According to the CBE register, the registered office of Exim Pharma is in 1050 Ixelles.
What is the equity of Exim Pharma?
At the close of the 2025 financial year, the equity of Exim Pharma amounts to -546,144 €, a solvency of -154.1% of total assets.
How many people work at Exim Pharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Exim Pharma?
The register lists 2 active mandates at Exim Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Exim Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →